DB3, LLC (FKA THE DASCHLE GROUP)

Lobbying for BIPARTISAN COMMISSION ON BIODEFENSE · Biodefense study panel

Filing 3rd Quarter - Termination

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.